glp-1 antidepressant Glucagon-like Peptide-1 receptor agonists as emerging therapeutics in bipolar disorder: a narrative review of preclinical and clinical evidence GLP-1s may alleviate depression through

Given multiple complications, the most severe one was taken into account

When you excrete excess water, you lose sodium, potassium, and magnesium along with it

doi: 10.1210/en.2012-1937

Short-acting GLP-1RAs slow down stomach emptying more than long-acting ones [2]

In clinical trials involving 17,183 patients, 50.2% of participants treated with GLP-1 receptor agonists lost at least 5% of their body weight, and 17.5% achieved a weight loss of 10% or more, both figures being significant compared to a placebo group

"This medication has led to significant amounts of weight loss, but when it stops, patients have reported gaining up to two-thirds of that weight back," Sutton said, citing published research